A THAOS Sub-Study Evaluating the Effects of Tafamidis on Disease Progression in Patients with non-V30M Mutations and Symptomatic Neuropathy

30/05/2013
14/03/2024
EU PAS number:
EUPAS4027
Study
Finalised
Documents
Study protocol
Initial protocol
English (526.91 KB - PDF) View document
Updated protocol
English (673.59 KB - PDF) View document
Study results
Study results
English (1.21 MB - PDF) View document
Study report
Study report
English (2.23 MB - PDF) View document
Other information